Posts Tagged "intravenous ketamine"

Ketamine: A Promising Novel Therapy for Anxiety and PTSD

  Article from Psychiatry Advisor: Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD).1,2...
Read More

Results of Randomized Trial Confirm Ketamine as Viable Non-opioid Alternative

Researchers at Cincinnati Children’s Hospital Medical Center have concluded that intranasal ketamine is as effective as intranasal fentanyl for the relief of pain from acute extremity injury in children. The findings from a recently completed randomized trial are important in...
Read More

Double-Blind Clinical Trial Shows that Dose Matters with Ketamine in Depressed Patients

The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal.  Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).  99 subjects, 18-70 years old with TRD…

Read More

The National Institute of Mental Health Highlights Ketamine for Depression

The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to play a…

Read More

IV Ketamine Shows Promise in Clinical Trial with Depressed Teens

Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and…

Read More

Yale study found no safety issues with long-term ketamine treatment

Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry.  In late 2014, Yale began providing ketamine as an off-label therapy on a case-by-case…

Read More

CNN Reports ‘Ketamine offers lifeline for suicidal thoughts’

CNN featured a segment on the use of ketamine for treating suicidal ideation–a novel, off-label use for ketamine that is currently being explored in human clinical trials.  The segment featured Dr. Sanjay Gupta sharing the story of Alan Ferguson.  Mr….

Read More

Ketamine alone beats methadone and methadone/ketamine combo for neuropathic pain

Neuropathic pain is notoriously difficult to treat.  Patients are often treated as regular chronic pain patients and many resort to opioids to manage extreme levels of pain. Neuropathic pain can originate from infection, metabolic diseases, chemotherapy, trauma and many other…

Read More

Ketamine is a new, faster option for treating PTSD

PTSD Treatment – Ketamine is a novel treatment for several psychiatric disorders including: Major Depressive Disorder, Bipolar Depression, Postpartum Depression, Obsessive-Compulsive Disorder (OCD), and Posttraumatic Stress Disorder or PTSD.  It was originally FDA approved for anesthesia but is now frequently...
Read More